gracecast - lcvl - can patients with an egfr mutation-positive advanced nsclc benefit from immunothe
Published 3 years ago • 82 plays • Length 10:39Download video MP4
Download video MP3
Similar videos
-
6:31
gracecast - lcvl - what is the best first line treatment for patients with advanced egfr mutation-po
-
5:24
gracecast - lcvl - can immunotherapy help frail patients with advanced nsclc
-
7:35
treatment for patients with egfr nsclc - leading developments & current questions in lung cancer
-
4:10
egfr mutations in advanced nsclc - targeted therapies in lung cancer 2023
-
9:26
gracecast - lcvl - which patients with advanced nsclc are good candidates for first line immunothera
-
33:47
gracecast-049_lung-cancer_weiss on egfr therapy for early stage nsclc
-
18:51
gracecast-140_lung_highlights in lung cancer, 2012: new options for egfr mutation-positive nsclc
-
8:58
gracecast - lcvl can egfr inhibitor therapy treat and prevent brain metastases
-
11:05
gracecast - lcvl - can immunotherapy help patients with small cell lung cancer
-
1:59
what is egfr and the egfr mutation?
-
11:13
gracecast-091_lung-cancer_highlights 2011: the egfr axis
-
6:26
metastatic egfr nsclc: recent developments - targeted therapies in lung cancer 2023
-
8:04
case based panel discussion 3.1 egfr mutation - chemotherapy and an egfr inhibitor concurrently or s
-
8:49
grace targeted therapies lung cancer 2021 - a role for chemo io in patients with egfr mutations?
-
7:54
keytruda combined with anti-vegf treatment:use in patients with advanced nsclc-asco lung review 2022
-
5:09
should a third generation egfr inhibitor be first line therapy for egfr mutation-positive nsclc?
-
9:18
gracecast - treatment options for metastatic nsclc
-
12:58
egfr inhibitor therapy in second line
-
7:48
should avastin be added to egfr tki therapy for egfr mutation-positive nsclc?